The Patent Finder

Cytotoxic Benzodiazepine Derivatives

ImmunoGen, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/443,062, filed Feb 15, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,889,669Cytotoxic Benzodiazepine Derivatives
In force
 · High confidence
UsedRemaining
ImmunoGen, Inc.In forceHigh confidence
US 9,169,272Cytotoxic Benzodiazepine Derivatives
In force
 · Medium confidence
ImmunoGen, Inc.In forceMedium confidence
US 9,840,564Cytotoxic Benzodiazepine Derivatives
In force
 · Medium confidence
ImmunoGen, Inc.In forceMedium confidence
US 10,179,818Cytotoxic Benzodiazepine Derivatives
In force
 · High confidence
ImmunoGen, Inc.In forceHigh confidence
US RE49,918Cytotoxic Benzodiazepine Derivatives
In force
 · Low confidence
ImmunoGen, Inc.In forceLow confidence
US 8,765,740Cytotoxic Benzodiazepine Derivatives
In force
 · High confidence
ImmunoGen, Inc.In forceHigh confidence
US 10,570,212Cytotoxic Benzodiazepine Derivatives
Surrendered on reissue Apr 16, 2024
High confidence
ImmunoGen, Inc.Surrendered on reissue Apr 16, 2024High confidence
US 9,434,748Cytotoxic Benzodiazepine Derivatives
Lapsed Sep 6, 2024 on the fee record
High confidence
ImmunoGen, Inc.Lapsed Sep 6, 2024 on the fee recordHigh confidence
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by ImmunoGen, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited